Siemens denies breakup plans
Siemens AG scrambled to deny a report this week in the Financial Times German edition that the company is planning “a radical restructuring.” The article implied that Siemens might sell several divisions, including its medical technology
Siemens AG scrambled to deny a report this week in the Financial Times German edition that the company is planning a radical restructuring. The article implied that Siemens might sell several divisions, including its medical technology business, in order to focus on information technology and communications.
In a press release issued by Siemens corporate headquarters in Erlangen, the company said statements attributed to CFO Heinz-Joachim Neubùrger were distorted and that a radical restructuring is not in the works. Specifically, Siemens said divestment of its energy, transportation, and healthcare segments was not being considered. In fact, healthcare is the companys fifth-most-profitable business segment, according to Joe Camaratta, VP of marketing for Siemens Medical Systems in Iselin, NJ.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
